Stryker Corp (NYSE:SYK)
A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
jrawk28
(33.83)
Submitted: 1/15/2012 12:33:20 PM :
Start Price:
$52.30
SYK Score:
-0.92
Aging demographics, no patent cliff as with pharmaceuticals.
Recs
getrichdietrying
(71.61)
Submitted: 1/11/2012 11:52:20 PM :
Start Price:
$52.23
SYK Score:
-1.19
http://www.cbsnews.com/8301-505245_162-57356541/stryker-4q-revenue-rises-11-percent/
"Sales from its neurotechnology and spine business grew about 47 percent. Sales grew about 11 percent in the fourth quarter."
Recs
torpeydo
(70.86)
Submitted: 11/15/2011 5:52:18 PM :
Start Price:
$48.72
SYK Score:
+2.24
baby boomers getting older
Recs
theojob
(< 20)
Submitted: 10/17/2011 10:42:25 PM :
Start Price:
$48.20
SYK Score:
-0.77
Quality care!
Recs
wsucougs
(36.63)
Submitted: 10/17/2011 4:54:44 PM :
Start Price:
$48.20
SYK Score:
-0.77
hips and knees. A couple of trends happening here.
1 - Boomers are getting older, and many will need new joints.
2 - The population is getting fatter. Weight is hard on joints
3 - Running is becoming more popular to fight weight gain, this is especially hard on joints.
Recs
Cardz
(< 20)
Submitted: 10/15/2011 10:23:36 AM :
Start Price:
$49.67
SYK Score:
-3.17
Slow and steady wins the race; SYK may not burn any barns, but its positioned to take advantage of a huge long-term trend in the medical field. People are replacing their hips, knees and other joints regularly now with better surgical techniques and longer life-spans, our bodies just were not built for the long-term abuse we subject them to and SYK will rake in profits as long as there are humans on this planet. I've been an avid investor in this company for decades.
Recs
Ken1171
(58.45)
Submitted: 9/4/2011 6:13:50 PM :
Start Price:
$45.69
SYK Score:
-0.27
Holding 4 aces
Recs
picbois
(93.51)
Submitted: 8/26/2011 11:56:49 PM :
Start Price:
$47.03
SYK Score:
+1.47
Will be stronger than the market because of good diversification of their business and because of the babyboomer trend that will need some medical assistance given in part by striker product
Recs
drewsd35
(< 20)
Submitted: 8/24/2011 12:55:58 AM :
Start Price:
$45.32
SYK Score:
+2.86
Great company and huge market grasp ridiculously strong business plan and growth
Recs
dentilfooling
(< 20)
Submitted: 8/18/2011 11:16:29 PM :
Start Price:
$43.74
SYK Score:
+3.45
ceramic implants not as likely to fail as all metal. Promise of new biologic
Recs
jocdocps
(69.69)
Submitted: 8/16/2011 2:35:04 PM :
Start Price:
$49.97
SYK Score:
-3.71
Current Quarter vs. Prior Year: For the third quarter 2011, analysts estimate SYK will earn $0.89 per share, an increase of 11.53% over the prior year third quarter results.
+15.7%Annualized 5 Year growth rate
Growth Rates
1 Yr 3 Yr 5 Yr
+7.4% +10.5% +15.7%
Recs
Trimalerus
(96.20)
Submitted: 7/28/2011 9:43:26 PM :
Start Price:
$53.14
SYK Score:
-3.47
Best price since last year on this Blue Chip stock. Having just acquired Orthovita they will bounce back to $65 or higher per share I expect. Aging boomer generation will create greater demand in this sector overall and Stryker is poised to pop. High Outperform ratio makes this a no brainier at this price.
Recs
k0stid0g004
(< 20)
Submitted: 3/17/2011 12:51:22 PM :
Start Price:
$59.84
SYK Score:
-15.52
Increased earnings estimates. Directors and officers are accumulating shares for above price today. Oversold. Seems like a good entry point.
Recs
tmcg1788
(37.05)
Submitted: 3/7/2011 10:32:44 AM :
Start Price:
$63.32
SYK Score:
-16.83
Well positioned as the economy recovers. Leader in their industry.
Recs
magicdart
(< 20)
Submitted: 10/31/2010 8:39:40 AM :
Start Price:
$48.78
SYK Score:
-3.08
Demographics will support market
undervalued on discounted future earnings
Recs
Jeffreyw
(98.17)
Submitted: 10/25/2010 12:57:51 PM :
Start Price:
$52.45
SYK Score:
-18.25
A leader in ortho products, should outperform as long as the quality of the products stand the test of a lifetime.
Recs
RedScourge
(96.76)
Submitted: 10/14/2010 3:38:26 AM :
Start Price:
$48.46
SYK Score:
-3.57
These guys are making great progress towards developing superpowers in humans...or at least that's what I took back from the X-Men movies...
Recs
tekwatchlist
(84.26)
Submitted: 9/22/2010 3:25:21 PM :
Start Price:
$46.02
SYK Score:
-6.17
Added 7/29/10
Recs
rockynicky
(< 20)
Submitted: 9/3/2010 6:58:54 AM :
Start Price:
$45.15
SYK Score:
-2.97
Strong demand for it's products. Good earnings.
Recs
tekennedy
(63.57)
Submitted: 8/16/2010 5:15:36 PM :
Start Price:
$45.39
SYK Score:
-3.48
A high ROE business with the ability to grow. Demographics should lead revenue to grow faster than market. Current pricing is attractive for longterm investors.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 200 : 1 2 3 4 5 6 7 8 9 10 Next »